BMS-791826

DB15023InvestigationalSmall molecule

BMS-791826 is under investigation in clinical trial NCT03198013 (A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males).

Formula / weight: C₂₈H₂₆FN₅O₃S · 531.61 g/mol (avg)
Code names: BMS-791826

Resolves to

Compound

UNII60BN6CDL0KCAS1008116-73-1

Structure

InChIKeyDZBKAUMYTFPJIS-QHCPKHFHSA-NSMILESCCN(C)C(=O)C1=CC=C(C=C1F)C1=NC2=C(C=C1)[C@H](C1=CC=CC=C1O2)C(C)(C)C(=O)NC1=NN=CS1

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of BMS-791826, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account